{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:36:51Z","timestamp":1794724611826,"version":"4.9.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Acute gastrointestinal (GI) toxicity is common in patients receiving pelvic radiotherapy (RT) and the small bowel (SB) is a dose-limiting organ at risk. There is a quandary in the dose constraints for SB while using intensity-modulated radiotherapy (IMRT) for gynecological malignancies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To investigate the correlation between the radiation dose received by SB and the incidence of acute lower GI toxicities, and to identify dose parameters that may reduce toxicity risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Fifty-eight patients diagnosed with gynecological cancers and received RT with IMRT technique were analyzed in this prospective observational study. Oral contrast was administered during the simulation scan as per institution protocol. The individual SB loops were delineated as per Radiation Therapy Oncology Group (RTOG) consensus guidelines. The volume of SB (cc) receiving 10, 15, 20, 30, and 40 Gy were analyzed. Grades of acute GI toxicities were assessed weekly according to RTOG scoring criteria. The odds of developing GI toxicities were analyzed using a logistic regression test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Out of the study population, 26 patients (45%) were diagnosed with carcinoma of the cervix, and 32 patients (55%) were diagnosed with carcinoma of the endometrium. 33 patients (57%) also received concurrent chemotherapy. Overall, Grade I, II, and III GI toxicities were observed in 32%, 62%, and 5% of patients, respectively. None of the patients developed GI toxicity during weeks 1 and 2 of RT. A significantly higher incidence of \u2265grade 2 GI toxicity was observed with a mean SB-V30 Gy &gt;210 cc (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001) and SB-V40 Gy &gt;103 cc (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). Patients with SB-V30 Gy \u2265210 cc had 2.2 times higher odds of developing \u2265 grade 2 enteritis compared to those with SB-V30 Gy &lt;210 cc (OR = 2.2; 95% CI, 1.5\u20136.3;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003). Likewise, the odds of developing \u2265grade 2 enteritis were 2.9 times higher in patients with SB-V40 Gy \u2265103 cc compared to those with SB-V40 Gy &lt;103 cc (OR = 2.90; 95% CI, 2.1\u20135.1;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Higher radiation doses to individual SB loops lead to a decrease in cellular reserves of intestinal mucosa resulting in \u2265grade 2 acute GI toxicity in patients receiving IMRT for gynecological malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2378_24","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T11:00:19Z","timestamp":1751713219000},"page":"644-648","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Prospective evaluation of small bowel dose and acute gastrointestinal toxicity during pelvic radiotherapy for gynaecologic malignancies"],"prefix":"10.4103","volume":"21","author":[{"given":"Febin","family":"Antony","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Amala Institute of Medical Sciences, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Philip","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amala Institute of Medical Sciences, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Jomon","family":"Raphael","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amala Institute of Medical Sciences, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Mathew","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amala Institute of Medical Sciences, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Rajkrishna","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amala Institute of Medical Sciences, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew P","family":"Jiniw","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Amala Institute of Medical Sciences, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minu","family":"Boban","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Amala Institute of Medical Sciences, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Narayan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Amala Institute of Medical Sciences, Thrissur, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"R1-20250707","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/ijgc-2021-002528","article-title":"Postoperative adjuvant radiation for cervix cancer: Reflections on the evidence and a peep into the future","volume":"32","author":"Chopra","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R2-20250707","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/ijgc-2021-002491","article-title":"Radiation oncology management of stage III and IVA cervical carcinoma","volume":"32","author":"Franco","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R3-20250707","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ijgc-2021-002472","article-title":"External beam management of stage I and II uterine cancer","volume":"32","author":"Edwards","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R4-20250707","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/ijgc-2021-002493","article-title":"Vaginal brachytherapy management of stage I and II endometrial cancer","volume":"32","author":"van","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R5-20250707","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ijgc-2021-002554","article-title":"Management of stage III and IVa uterine cancer","volume":"32","author":"Nero","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20250707","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1002\/cncr.28849","article-title":"Complications of pelvic radiation in patients treated for gynecologic malignancies","volume":"120","author":"Viswanathan","year":"2014","journal-title":"Cancer"},{"key":"R7-20250707","first-page":"802","article-title":"Frequency and severity of acute toxicity of pelvic radiotherapy for gynecological cancer","volume":"25","author":"Hafiz","year":"2015","journal-title":"J Coll Physicians Surg Pak"},{"key":"R8-20250707","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rpor.2012.07.005","article-title":"Incidence of radiation toxicity in cervical cancer and endometrial cancer patients treated with radiotherapy alone versus adjuvant radiotherapy","volume":"17","author":"Roszak","year":"2012","journal-title":"Rep Pract Oncol Radiother"},{"key":"R9-20250707","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.clon.2021.04.009","article-title":"Gastrointestinal toxicity of pelvic radiotherapy: Are we letting women down?","volume":"33","author":"Fernandes","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R10-20250707","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.canrad.2010.03.013","article-title":"Dose de tol\u00e9rance \u00e0l'irradiation des tissus sains: Intestin gr\u00eale [Normal tissue tolerance to external beam radiation therapy: Small bowel","volume":"14","author":"Martin","year":"2010","journal-title":"Cancer Radiother"},{"key":"R11-20250707","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.v19.i2.185","article-title":"Gastrointestinal radiation injury: Symptoms, risk factors and mechanisms","volume":"19","author":"Shadad","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R12-20250707","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncologye-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"R13-20250707","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13014-018-1126-7","article-title":"Intensity-modulated radiation therapy for definitive treatment of cervical cancer: A meta-analysis","volume":"13","author":"Lin","year":"2018","journal-title":"Radiat Oncol"},{"key":"R14-20250707","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/ajco.12049","article-title":"Small bowel toxicity in pelvic radiotherapy for postoperative gynecological cancer: Comparison between conformal radiotherapy and intensity modulated radiotherapy","volume":"9","author":"Ray","year":"2013","journal-title":"Asia Pac J Clin Oncol"},{"key":"R15-20250707","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.radonc.2014.01.018","article-title":"Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: Results of the phase II RTCMIENDOMETRE French multicentre trial","volume":"111","author":"Barillot","year":"2014","journal-title":"Radiother Oncol"},{"issue":"(Suppl 3)","key":"R16-20250707","first-page":"82","article-title":"Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis","volume":"174","author":"Classen","year":"1998","journal-title":"Strahlenther Onkol"},{"key":"R17-20250707","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2378_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:52:32Z","timestamp":1786647152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2378_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2378_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-12-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}